Objectives: After attending the session, attendees should be able to:
* Discuss expectations & results associated with facial rejuvenation with different treatment modalities including lasers and injectables.
* Outline principles of selection of the appropriate modality for facial rejuvenation..
* Describe measures to minimize complications and sub-optimal results of lasers and injectables.
* Discuss benefits, expectations, & results associated with injectables and lasers in facial rejuvenation.

Introduction: Facial Rejuvenation is becoming a widely demanded service in the Cosmetic Dermatology and Aesthetic Surgery fields. Many techniques and procedures are being practiced to improve the skin condition and appearance.
The pathogenesis of skin aging and the factors influencing it should be kept in mind to select the suitable technique/procedure. In most of the cases, the pathology is multilevel and affecting more than one layer of the skin and dealing with only one layer would not give the optimum outcome.

Materials / method: While designing a rejuvenation plan for a patient, it is mandatory to be able to assess the altered anatomy and physiology of the skin and structures we work on. Once, we understand the pathology and the impairment of the structure and the function of each layer of the skin we will work on, we will be in a better position to decide what kind of combination therapy we will advise the patient to undergo. If it is decided to do a combination of lasers, energy based devices, fillers or neurotoxins, the next question will be which comes first.

Conclusion: Different scenarios will be presented during an interesting oral presentation with brain storming and live discussions with the attendees about how to plan and which comes first among the different procedures.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Objectives: Introduce the concept of microcoring and show 2 different approaches to this treatment.

Introduction: Skin tightening without surgery has been an elusive goal. A novel approach to this goal is to remove small cores of skin which will lead to relative tightening once wound healing is complete.

Materials / method: Nonthermal microcoring study results will be summarized. The concept of "laser coring" will be introduced treatment discussed

Results: Outcomes including clinical photos from both thermal and nonthermal microcoring studies and treatments will be discussed

Conclusion: Microcoring can be a useful approach to nonsurgical skin tightening. This goal may be accomplished using thermal and nonthermal techniques. Additional data is required to draw further conclusions about optimal treatment paraments and patient selection.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
是
请注明名称（个人，公司，学会等等）: Sofwave, Acclaro

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Objectives: The field of laser assisted drug delivery is rapidly expanding. The interaction between laser and immune system has recently been explored.

Introduction: Laser assisted drug delivery in photodynamic therapy is quite helpfull in tackling the skin cancer epidemic, especially for basal cell carcinoma and morbus Bowen.

Materials / method: During the presentation a survey of the experience of the last decade with this new approach to skin cancer treatments will be discussed.

Results: The outcome in skin cancer treatments is quite remarkable. Factors influencing the effectiveness of this treatment modality will be highlighted.

Conclusion: Photodynamic therapy in combination with laser assisted drug delivery may become a game changer in treating basal cell carcinoma and morbus Bowen.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。